Abstract:
Objective To investigate the expression and clinical significance of PD-L1 in colorectal cancer(CRC).
Methods A total of210 CRC patients who accepted radical surgery in our hospital from January 2015 to January 2016 were divided into three groups, namely, high-frequency microsatellite instability(MSI-H), low-frequency microsatellite instability(MSI-L), and microsatellite stable(MSS).The expression of PD-L1 was detected by immunohistochemistry, and the expression characteristics of PD-L1 in different typesof CRC were analyzed.
Results CRC cases with low differentiation had a higher expression of PD-L1 than CRC patients with high differentiation(P < 0.05).PD-L1 had a positive rate of 75.8% in the MSI-H group and a rate of 9.3% in the MSI-L and MSS groups, wherein thedifference between the two groups was statistically significant(P < 0.05).
Conclusion D-L1 was positively expressed in some CRC tumor tissues, and its positive rate was significantly higher in MSI-H than in MSI-L and MSS.The therapeutic effect of a PD-L1 blocker forpatients with MSI-H CRC might be preferable.